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Why Should We Care?
Volume of health research is increasing
more researchers, more collaborations, more research subjects, more money
more opportunity to benefit (and harm) persons as well as international relations 
between institutions and countries
More involvement of pharmaceutical companies
Inequity in research in developing countries remains
10/90 gap: only 10% of all research money is being spent on diseases that affect 90% 
of the world’s people
Controversial studies are being reported
Placebo-controlled perinatal HIV transmission studies
Collection of genetic samples in China without consent
Increasing concern about the “export” of U.S. regulations
Increasingly seen as ‘paternalistic
Research is becoming a topic of interest beyond health circles
Economic development, Trade policy, National Security
What Does It Mean to Say That Something (Someone) 
Is Ethical (Or Unethical)?
Traditional moral theory often distinguishes between
Actions or behaviors (e.g., ends, rules)
Character of the actor (e.g., traits, virtues)
Bioethics often adds additional components
Procedures (e.g., fair process)
Satisfaction of certain principles, standards
Neither approach is completely satisfactory
The problem of universalizability
The problem of incommensurability
What Should We Ask?
Why are we going there?
Justification
How will we behave when we are there?
Conduct of the study
What will we do when we leave?
Post-trial benefits
What Makes Clinical Research 
in Developing Countries Ethical?
Principles
Collaborative partnership
Social value
Scientific validity
Fair selection of study population
Favorable risk-benefit ratio
Independent review
Informed consent
Respect for recruited participants and study communities
– Emanuel, et al, Journal of infectious Diseases (2004)
From Principles to Benchmarks
Principle: Collaborative Partnership
Benchmarks:
• Develop partnership
• Share responsibilities for determining problem, assessing value,
planning, conducting, oversight, integration
• Respect community values, culture, tradition, social practices
• Develop capacity to become true partners
• Ensure that participants benefit from research
• Share fairly the financial and other rewards
From Benchmarks to Implementation
Benchmark: Respect community values, culture, tradition, social 
practices
Implementation issues:
• Meaning:
– What does “should respect” mean? Is it like “should consider”? 
– And if so, does it mean: “be mindful of”,  “be aware of”, “be 
sensitive to”, (which are desirable practices that may contribute to 
productive collaboration)
– Or does it mean : “should adopt where possible”, “should make 
reference to”, or “should rely on”? (which may result in 
disagreement) 
• Resolving disagreements
– Difficult to compromise on traditions (social norms and practices)
– Who decides?
From Benchmarks to Implementation
Benchmark: Ensure that participants benefit from research
Implementation issues:
• Meaning:
– What does “benefit” mean? 
– Drug? Roads? Infrastructure?
– Limited to trial participants? What about communities?
– On whose shoulders does any obligation to provide benefit fall?
From Principles to Benchmarks
Principle: Informed Consent
Benchmarks:
• Involve the community in establishing  recruitment procedures and 
incentives
• Disclose information in culturally and linguistically formats
• Implement supplementary community and familial consent procedures 
where culturally appropriate
• Obtain consent in culturally and linguistically formats
• Ensure freedom to refuse or withdraw
From Benchmarks to Implementation
Benchmark: Obtain consent in culturally and linguistically 
formats
Implementation Issues:
• Western legal tradition as the origin of the concept is not universal
• Federal regulations specify written consent with exceptions; in many 
countries the reverse is true
• Consent involving men and women differ
• Therapeutic misconception
Solutions
Top Down
Harmonization of rules, regulations
Regulatory reform
Bottom Up
Prior agreements
Capacity building
Top Down:
Harmonization of Guidelines
CIOMS 
Council of Europe
Declaration of Helsinki
International 
Conference on 
Harmonization
UNAIDS
UNESCO Declaration on 
the Human Genome
WHO Operational 
Guidelines
European Privacy 
Directive

Harmonization Efforts
Harmonization difficulties:
Incomplete coverage within the U.S. regulations
• Leads to lack of guidance for U.S. institutions
Non-overlapping issues in international documents
• Placebos
• Consent
• Ethics review
• Gender issues
• Privacy
Specific issues not covered in all documents
• Genetics
• Health services/outcomes research
• Social and behavioral research
Regulatory Reform
Equivalent protection:
US research regulations permit DHHS Secretary to declare that 
another country may substitute their guidelines for US guidelines, if 
the host country/institution has a system of substantive protections 
that are equivalent to the U.S. system
• Is this paternalistic?
• What of countries that have superior standards to the US?
However: no countries/guidelines have been determined by the 
U.S. to provide protections equivalent to those of U.S.
Bottom Up:
Prior Agreements
Specifies terms and conditions of research relationship
Responsibilities of partners
Criteria for entry into a country
Access to post-trial benefits
Resolving disagreements in advance
Negotiations between host and sponsor
Enhances partnership
Bottom Up: Capacity Building
MOU between Moi University 
College of Health Sciences and 
IU School of Medicine
Followed a 3-day workshop in 
Kenya in 1993
Extensive discussions about 
research protocols and common 
problems
What Makes International Research Ethical (Or 
Unethical)?
An Initial list
Compliance with substantive and procedural protections
Attention to the difficulties in accommodating cultural issues
Appreciation of the dialectic that occurs in all international relations
Recognition of the risk of imposing a “double standards”
The challenge of pragmatic vs. aspirational arguments
